SCHEMBL14933691

SCHEMBL14933691

COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)C2[C@@H]1[C@@H]1CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]2OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 5/20 0.69
▸ PGR P06401 5/20 0.69
▸ AR P10275 4/20 0.69
▸ NR3C2 P08235 3/20 0.69
▸ LMNA P02545 5/20 0.55
▸ CHRM2 P08172 3/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ OPRK1 P41145 2/20 0.55
▸ ABCB11 O95342 2/20 0.55
▸ HTR2B P41595 2/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ ESR1 P03372 1/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ ADRA1A P35348 1/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ SLC47A1 Q96FL8 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14568580 1.00 NR3C1 (0.69) NR3C1PGRARNR3C2LMNA
SCHEMBL14565706 0.93 PGR (0.66) NR3C1PGRARNR3C2LMNA
SCHEMBL14284946 0.93 PGR (0.66) NR3C1PGRARNR3C2LMNA
SCHEMBL14285009 0.91 NR3C1 (0.67) NR3C1PGRARNR3C2LMNA
SCHEMBL14284952 0.91 NR3C1 (0.67) NR3C1PGRARNR3C2LMNA
SCHEMBL14084961 0.90 NR3C1 (0.70) NR3C1PGRARNR3C2LMNA
SCHEMBL14567812 0.90 NR3C1 (0.70) NR3C1PGRARNR3C2LMNA
SCHEMBL14450055 0.90 NR3C1 (0.70) NR3C1PGRARNR3C2LMNA
SCHEMBL14508986 0.90 NR3C1 (0.70) NR3C1PGRARNR3C2LMNA
SCHEMBL14565704 0.90 NR3C1 (0.70) NR3C1PGRARNR3C2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013064620-A1 18-METHYL-6,7-METHYLENE-3-OXO-17-PREGN-4-ENE-21,17Β-CARBOLACTONES, PHARMACEUTICAL PREPARATIONS COMPRISING SAID COMPOUNDS AND USE THEREOF IN THE TREATMENT OF ENDOMETRIOSIS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-05-10 — — WO disclosed
Send feedback